| Available Now!
Work as a unified force to reduce your risks
The Recovery Audit Contractor (RAC) program is here to stay. So what’s the number-one RAC risk associated with a hospital’s billing of drugs under the Medicare Outpatient Prospective Payment System (OPPS)? Coding mistakes? Billing errors? MedLearn’s consulting experts have determined that the root issue is this: The various individuals involved in the hospital pharmacy revenue stream often don’t clearly understand their responsibilities or how their information systems impact other aspects of the reimbursement and compliance picture. From this MedLearn webcast, you’ll gain a big-picture view of how effective coordination and communication play a huge role in neutralizing RAC risks. Highlights:
- A review of the RAC risk for hospital pharmacies — what auditors are targeting, why and how they’re doing it and the implications of noncompliance
- Which drugs have attracted the attention of RAC auditors and which ones will likely be audit candidates in the future
- Understanding the effects — downstream and upstream — inherent with workflows between disparate clinical and revenue management information systems
- Strategies for communication and coordination among the full spectrum of individuals who have coding, billing and compliance responsibilities
- Tactics for avoiding specific errors related to billing units, HCPCS code assignments and code description revisions
- A 30-minute Q&A session — an opportunity to get answers to the most frequently asked questions
About our presenter
This MedLearn webcast is presented by Randy Wiitala, BS, MT (ASCP), a MedLearn senior healthcare consultant since 1991. His areas of expertise include chargemaster review and management for critical access and OPPS hospitals, revenue assurance, and regulatory compliance. Mr. Wiitala contributes to a variety of MedLearn publications and electronic products that help providers maintain revenue streams and regulatory compliance for pharmacy, respiratory therapy and laboratory services. His professional career includes experience as a medical technologist in rural and urban hospitals, marketing manager for a Fortune 500 pharmaceutical company and product development/regulatory affairs specialist with a multinational diagnostics testing firm.
|
